Asaf Danziger
Net worth: 7 M $ as of 31/05/2026
Net worth: 7 M $ as of 31/05/2026
Currently, Asaf Danziger occupies the position of Chief Executive Officer & Director at NovoCure Ltd. and Co-Managing Director at NovoCure GmbH (a subsidiary of NovoCure Ltd.). In the past Mr. Danziger occupied the position of Chief Executive Officer of Cybro Medical Ltd. and Communications & Electronics Officer at Israel Defense Forces. He received an undergraduate degree from Ben-Gurion University of the Negev.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVOCURE LTD. 0.36% | 06/04/2026 | 411,500 ( 0.36% ) | 7 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| NOVOCURE LIMITED | Director/Board Member | 01/01/2012 |
NovoCure GmbH
NovoCure GmbH Pharmaceuticals: MajorHealth Technology Develops proprietary therapy | Chief Executive Officer | 01/01/2012 |
| Companies | Position | End |
|---|---|---|
Cybro Medical Ltd. | Chief Executive Officer | 01/01/2002 |
NanoPass Technologies Ltd.
NanoPass Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Director/Board Member | - |
Israel Defense Forces
Israel Defense Forces SovereignGovernment National security | Corporate Officer/Principal | - |
ID-U Biometrics Ltd.
ID-U Biometrics Ltd. BiotechnologyHealth Technology Develops multivariate dynamic biometrics system | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NanoPass Technologies Ltd.
NanoPass Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Israel Defense Forces
Israel Defense Forces SovereignGovernment National security | Government |
NovoCure Ltd.
NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
ID-U Biometrics Ltd.
ID-U Biometrics Ltd. BiotechnologyHealth Technology Develops multivariate dynamic biometrics system | Health Technology |
Cybro Medical Ltd. | Technology Services |
NovoCure GmbH
NovoCure GmbH Pharmaceuticals: MajorHealth Technology Develops proprietary therapy | Health Technology |
Select your edition
All financial news and data tailored to specific country editions